Home » AstraZeneca Paying for Development of Drug
AstraZeneca Paying for Development of Drug
A British medical technology company plans to start clinical trials on an experimental diabetes
drug that AstraZeneca will have the option to license.
The News Journal
The News Journal
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May